Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer

Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer

Objectives: Measurement of lipoprotein(a) [Lp(a)] is used in risk assessment of atherosclerotic cardiovascular disease (ASCVD). The aim of the current study was to evaluate performance characteristic of five different Lp(a) assays using the cobas c501 (Roche Diagnostics) analyzer. Design and methods...

Full description

Bibliographic Details
Main Authors:	Sara P. Wyness, Jonathan R. Genzen
Format:	Article
Language:	English
Published:	Elsevier 2021-05-01
Series:	Practical Laboratory Medicine
Subjects:	Lipoprotein Lipoprotein(a) Atherosclerotic cardiovascular disease Lipids Harmonization Standardization
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352551721000184

Similar Items

Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer
by: Genzen, J.R, et al.
Published: (2021)

Lipid and lipoprotein profiles among middle aged male smokers: a study from southern India
by: Ramachandran Meenakshisundaram, et al.
Published: (2010-10-01)

Hypertriglyceridemia and atherosclerosis
by: Jia Peng, et al.
Published: (2017-12-01)

Comparative study of low density lipoprotein by estimation and calculation from lipid profile in a tertiary hospital
by: Lavanya Lagisetty, et al.
Published: (2020-01-01)

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
by: Saeed Shoar, et al.
Published: (2021-06-01)

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States
by: Alexa C. Klimchak, et al.
Published: (2020-03-01)

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection
by: Julius U
Published: (2016-10-01)

Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.
by: Peter P. Toth, MD, PhD
Published: (2021-06-01)

Lipidomic profile in patients with a very high risk of atherosclerotic cardiovascular disease on PCSK9 inhibitor therapy
by: Kui Huang, et al.
Published: (2021-06-01)

LAS LIPOPROTEÍNAS DE ALTA DENSIDAD: PROTECTORAS VASCULARES CONTRA LA ATEROSCLEROSIS / High-density lipoproteins: vascular guards against atherosclerosis
by: Yosit Ponce Gutiérrez, et al.
Published: (2013-10-01)

Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation
by: Carlo Maria Barbagallo, et al.
Published: (2021-04-01)

Lipid and Lipoprotein Metabolism in Microglia
by: Bailey A. Loving, et al.
Published: (2020-04-01)

Lipoprotein subclass analysis by immunospecific density
by: Lester, Sandy Marie
Published: (2010)

Analysis of cholesterol levels in lipoprotein(a) with anion-exchange chromatography
by: Yuji Hirowatari, et al.
Published: (2010-05-01)

Obstructive sleep apnea and effects of continuous positive airway pressure on triglyceride-rich lipoprotein metabolism[S]
by: Luciano F. Drager, et al.
Published: (2018-01-01)

Partial separation and characterization of human serum low density lipoprotein
by: Whitfill, Craig Everett, 1944-
Published: (1969)

The effect of an oral lipid load on plasma lipids, apolipoproteins and lipoproteins.
Published: (1992)

The role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases
by: Malihe Aghasizadeh, et al.
Published: (2020-06-01)

Lipoprotein subclass metabolism in nonalcoholic steatohepatitis[S]
by: Ville T. Männistö, et al.
Published: (2014-12-01)

HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE
by: Stephen J. Nicholls, et al.
Published: (2020-10-01)

The isolation of lipoproteins from human plasma by ultracentrifugation in zonal rotors
by: HENRY G. WILCOX, et al.
Published: (1971-03-01)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
by: Fumiaki Ito, et al.
Published: (2020-04-01)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
by: Jan Borén, et al.
Published: (2020-07-01)

Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
by: Agarwala A, et al.
Published: (2021-05-01)

Lipoproteins and other risk factors for cardiovascular disease in a student population
by: Pap Dragana, et al.
Published: (2013-01-01)

1H NMR spectroscopy quantifies visibility of lipoproteins, subclasses, and lipids at varied temperatures and pressures
by: Daniela Baumstark, et al.
Published: (2019-09-01)

Serum Non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study
by: Balluz Lina S, et al.
Published: (2011-05-01)

A comparative study on serum lipoprotein (a) and lipid profile between rheumatoid arthritis patients and normal subjects
by: K P Shiva Govindan, et al.
Published: (2015-01-01)

Analyzing the molecular mechanism of lipoprotein localization in Brucella
by: Shivani eGoolab, et al.
Published: (2015-10-01)

Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis
by: Xian-Cheng Jiang
Published: (2018-01-01)

Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet
by: Nastaran Faghihnia, et al.
Published: (2010-11-01)

Interaction Effects of Lipoprotein Lipase Polymorphisms with Lifestyle on Lipid Levels in a Korean Population: A Cross-sectional Study
by: Jung-A Pyun, et al.
Published: (2012-06-01)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
by: Toth PP
Published: (2016-05-01)

New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases
by: Xin Su, et al.
Published: (2018-01-01)

Serum Lipid and Lipoproteins in Gallstone Patients
by: Naciye Kurtul, et al.
Published: (2002-01-01)

Metabolic fate of rat and human lipoprotein apoproteins in the rat
by: Shlomo Eisenberg, et al.
Published: (1973-07-01)

Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study
by: Xiangming Hu, et al.
Published: (2020-07-01)

The impact of Niacin on PCSK9 levels in vervet monkeys (Chlorocebus aethiops)
by: Ngqaneka, Thobile
Published: (2021)

The role of high density lipoprotein compositional and functional heterogeneity in metabolic disease
by: Gordon, Scott M.
Published: (2012)

The effect of dynamic resistance training on lipoprotein - lipid profiles
Published: (2008)